Back
Fidelity Low Duration Bond Factor ETF Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Sell
46
FLDR
Fidelity Low Duration Bond Factor ETF
Last Price:
$50.32
Seasonality Move:
-0.28%
Sell
39
MNPR
Monopar Therapeutics, Inc.
Last Price:
$71.43
Seasonality Move:
36.18%
Sell
46
Fidelity Low Duration Bond Factor ETF (FLDR)
is a Sell
Is Fidelity Low Duration Bond Factor ETF a Buy, Sell or Hold?
-
The current Fidelity Low Duration Bond Factor ETF [FLDR] share price is $50.28. The Score for FLDR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
FLDR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $75.12. The Score for MNPR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FLDR Stock Price Chart
What is Fidelity Low Duration Bond Factor ETF's stock price today?
-
The Fidelity Low Duration Bond Factor ETF share price today is $50.28Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FLDR is experiencing selling pressure, which indicates risk of future bearish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $75.12Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.
FLDR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 46.03 | Sell |
| Chaikin Money Flow: | -75214 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.25 - 50.35) | Sell |
| Bollinger Bands (100): | (50.2 - 50.36) | Sell |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.87 | Sell |
| Relative Strength Index (14 RSI): | 42.12 | Sell |
| Chaikin Money Flow: | -62944 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (76.34 - 86.56) | Sell |
| Bollinger Bands (100): | (44.09 - 88.71) | Buy |
FLDR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.27 | Buy |
| 20-day SMA: | 50.3 | Sell |
| 50-day SMA: | 50.32 | Sell |
| 200-day SMA: | 50.17 | Buy |
| 8-day EMA: | 50.28 | Buy |
| 20-day EMA: | 50.29 | Sell |
| 50-day EMA: | 49.26 | Buy |
| 200-day EMA: | 31.23 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 77.09 | Sell |
| 20-day SMA: | 81.11 | Sell |
| 50-day SMA: | 83.94 | Sell |
| 200-day SMA: | 51.58 | Buy |
| 8-day EMA: | 77.09 | Sell |
| 20-day EMA: | 79.63 | Sell |
| 50-day EMA: | 78.25 | Sell |
| 200-day EMA: | 56.2 | Buy |
Fidelity Low Duration Bond Factor ETF Earnings Growth & FLDR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
Fidelity Low Duration Bond Factor ETF Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||